
Seasonal influenza is an acute respiratory infection caused by influenza viruses which circulate in all parts of the world. It spreads easily, with rapid transmission in crowded areas including schools.
SYMPTOMS
Seasonal influenza is characterized by a sudden onset of fever, cough (usually dry), headache, muscle and joint pain, severe malaise (feeling unwell), sore throat and a runny nose. The cough can be severe and can last 2 or more weeks.
Most people recover from fever and other symptoms within a week without requiring medical attention. But influenza can cause severe illness or death especially in people at high risk.
DIAGNOSTIC
The majority of cases of human influenza are clinically diagnosed.
Collection of appropriate respiratory samples and the application of a laboratory diagnostic test is required to establish a definitive diagnosis. Proper collection, storage and transport of respiratory specimens is the essential first step for laboratory detection of influenza virus infections.
Laboratory confirmation of influenza virus from throat, nasal and nasopharyngeal secretions or tracheal aspirate or washings is commonly performed using direct antigen detection, virus isolation, or detection of influenza-specific RNA by reverse transcriptase-polymerase chain reaction (RT-PCR).
PREVENTION
The most effective way to prevent the disease is vaccination.
EPIDEMIOLOGY
Seasonal influenza represents a year-round disease burden. It causes illnesses that range in severity and sometimes lead to hospitalization and death.
Worldwide, these annual epidemics are estimated to result in about 3 to 5 million cases of severe illness, and about 290,000 to 650,000 respiratory deaths.
REFERENCES
-
Warren-Gash C, et al. (2018) Laboratory-confirmed respiratory infections as triggers for acute myocardial infarction and stroke: a self-controlled case series analysis of national linked datasets from Scotland. Eur Resp J 51:1701794; DOI: 10.1183/13993003.01794-2017
Date Accessed: June 30, 2023 -
Kubale J, et al. (2021) Individual-level association of influenza infection with subsequent pneumonia: a case-control and prospective cohort study. Clin Infect Dis 73:e4288-e4295; DOI: 10.1093/cid/ciaa1053
Date Accessed: June 30, 2023 -
WHO Influenza Fact Sheet. https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal)
Date Accessed: June 30, 2023
Frequently Asked Questions
COMING SOON
Browse through medical articles
COMING SOON
Browse through on-demand medical videos

From Lab to Jab: The Journey of Vaccine Creation
March 2025
Sanofi has been committed to developing and delivering innovative vaccines for over 100 years, contributing to global health protection.


Panel Discussion on Vaccination and the Philippine Health Systems
February 2024
RealTALK: Vaccine Expert Dr. Rontgene Solante

Impact of Flu on Cardio
June 2023
How does influenza lead to an increase of cardiovascular events?

Influenza Vaccination After Myocardial Infarction (IAMI)
December 2023
Are you aware that contracting the flu may heighten your chances of experiencing a heart attack?
Listen through medical discussions
COMING SOON
Browse through different medical cources
COMING SOON
Explore upcoming medical events

Safeguarding High-Risk Groups: The Importance of Flu Vaccination and Effective Communication
April 2025
Webinar discussion on the importance of flu vaccination and effective communication

Vaccination in Pregnancy: An Essential Component of Antenatal Care
April 2025
Webinar discussion on Vaccination in Pregnancy: an essential component of antenatal care
Explore downloadable medical resources
MAT-PH-2301173 | VER 1.0 | DA 11-2023 | DM 11-2023
Adverse events & product safety
If you experience any adverse event, i.e., anu unfavorable and unintended sign (an abnormal laboratory finding), symptom, or disease temporarily associated with the use of a medical product, please email it to PV.Philippines@sanofi.com
For Data Privacy requests and concerns:
Sanofi General Medicines (under sanofi-aventis Philippines, Inc.) and Sanofi Vaccines (under Sanofi Pasteur, Inc.): OneTrust
Adverse events & product safety
If you experience any adverse event, i.e., anu unfavorable and unintended sign (an abnormal laboratory finding), symptom, or disease temporarily associated with the use of a medical product, please email it to PV.Philippines@sanofi.com
For Data Privacy requests and concerns:
Sanofi General Medicines (under sanofi-aventis Philippines, Inc.) and Sanofi Vaccines (under Sanofi Pasteur, Inc.): OneTrust
Adverse events & product safety
If you experience any adverse event, i.e., anu unfavorable and unintended sign (an abnormal laboratory finding), symptom, or disease temporarily associated with the use of a medical product, please email it to PV.Philippines@sanofi.com
For Data Privacy requests and concerns:
Sanofi General Medicines (under sanofi-aventis Philippines, Inc.) and Sanofi Vaccines (under Sanofi Pasteur, Inc.): OneTrust